Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Time to move over.......<br />
It’s time to say goodbye<br />
to my role as editor and<br />
publisher of New Zealand<br />
Optics. When I was<br />
first involved in purchasing<br />
the magazine from Barbara<br />
Vague some 34½ years ago<br />
I would never have guessed<br />
that I would spend more than<br />
half my life involved in the<br />
ophthalmic industry. And what<br />
a rollercoaster ride it has been!<br />
I’d like to thank all my<br />
friends and colleagues in<br />
ophthalmology, optometry,<br />
dispensing and the wider<br />
industry including the<br />
university and the many<br />
wholesalers and distributors<br />
for their trust in me and their<br />
support over the years.<br />
For a non-optometrist<br />
and ophthalmologist I feel<br />
privileged to have learnt<br />
so much about your world<br />
whether it be eye conditions,<br />
eye disease, eye surgery,<br />
ophthalmic drugs, the design<br />
of frames and lenses to name<br />
just a few. It’s also been a<br />
privilege to have been involved<br />
in the technological advances<br />
which have transformed this<br />
industry since joining it in the<br />
early 80s. One thing for sure,<br />
these changes are going to<br />
continue to happen and that’s<br />
what has made my job so<br />
exciting.<br />
I’ve had the immense<br />
pleasure to meet people all<br />
around the world associated<br />
with your professions and<br />
industry. Too many highlights<br />
to mention individually<br />
BY MARYANNE DRANSFIELD<br />
but certainly the Essilor<br />
educational conferences held in<br />
Asia would have to be up there,<br />
as well as the 40th anniversary<br />
of Silmo in France.<br />
There have been many<br />
people who have helped<br />
us to make the magazine<br />
the success it is. I’d like to<br />
single out Alan Saks who has<br />
relentlessly churned out a<br />
monthly In Contact column<br />
for over 20 years; Professor<br />
Charles McGhee for having<br />
the insight to develop the Eye<br />
on Ophthalmology column so<br />
research and developments<br />
in ophthalmology got some<br />
exposure, and for orchestrating<br />
along with Associate Professor<br />
Dipika Patel the many people<br />
who have contributed to this<br />
over the years; and Dr Sue<br />
Ormonde whose idea it was<br />
to develop the regular Focus<br />
on Research contribution.<br />
Also thank you to the various<br />
contributors of Focus on<br />
Business, a very worthwhile,<br />
topical column that plays a role<br />
in shaping your businesses.<br />
A special mention too for Dr<br />
Bruce Hadden who kindly<br />
guided the way so we could<br />
embrace ophthalmology in the<br />
magazine. Also a huge thanks<br />
to my business partner and<br />
daughter-in-law Anita who has<br />
worked with me for the past 12<br />
years. She has played a big part<br />
in growing the magazine and<br />
the Optical Information Guide.<br />
It’s the end of an era for<br />
my entire family. All three of<br />
my children have worked in<br />
The familiar faces of Maryanne and Anita Dransfield at work at<br />
ODMA|<strong>2015</strong><br />
the business at some stage<br />
and have gotten to know<br />
many of you. Now there are<br />
seven grandchildren who are<br />
mightily relieved they don’t<br />
have to become involved in<br />
sticking labels on bags or<br />
inserting copies.<br />
It’s time to explore new<br />
ventures and take a welldeserved<br />
break with some<br />
travel high on the priority list.<br />
Anita and her family are off for<br />
a year’s travel overseas later<br />
this year before their two girls<br />
start secondary school.<br />
Anita and I have handed over<br />
the reins to Lesley Springall,<br />
a very competent journalist<br />
whom I am sure will take the<br />
magazine to the next level.<br />
Simon Eskow has joined Lesley<br />
as editor. However, I can assure<br />
you that it is business as usual<br />
and we are both continuing<br />
to work with Lesley over the<br />
coming months to ensure that<br />
she is fully settled and gets<br />
a chance to meet everyone. I<br />
will also be continuing with<br />
the publication in a new role<br />
as editor-at-large, where I will<br />
continue to represent NZ Optics<br />
at various industry events<br />
and help Lesley make sure we<br />
continue to keep everyone<br />
informed of what’s going on,<br />
both here and overseas.<br />
Whatever the future holds,<br />
optics will always be close to<br />
my heart. Sincere best wishes<br />
to everyone in this stimulating<br />
and dynamic industry and<br />
thank you for the opportunity<br />
of bringing the changing world<br />
of optics to you for all these<br />
years and for the fun we have<br />
had! O<br />
Rodenstock quashes sale<br />
rumours and eyes NZ<br />
Rodenstock, one of<br />
the world’s biggest<br />
frames and lens<br />
manufacturers, is<br />
not going through any sort of<br />
official sale process, despite<br />
persistent rumours to the<br />
contrary.<br />
Tim McCann, general manager<br />
of Rodenstock Australia,<br />
quashed the rumours in an<br />
interview with NZ Optics shortly<br />
after ODMA. Hearsay is par for<br />
the course for the company<br />
given it’s owned by UK-based<br />
international private equity<br />
company Bridgepoint and a<br />
number of other financiers.<br />
Tim McCann<br />
There are strong rumours that<br />
there is an interested party, said<br />
McCann. “But we don’t know who it is at this stage. The one thing<br />
that is certain and I have an absolute emphatic response on is it’s<br />
definitely not Essilor or Hoya.”<br />
Many were speculating about Rodenstock’s potential sale at<br />
ODMA|<strong>2015</strong> this year following an article by Bloomberg Business in<br />
May, which named rival lens manufacturers Essilor International<br />
and Hoya Corp among suitors said to be weighing bids for their<br />
German competitor. Bridgepoint is said to have hired investment<br />
bank Goldman Sachs Group to look at options for the company<br />
earlier this year with any sale likely to fetch more than 500 million<br />
euros ($825 million) for Rodenstock’s shareholders.<br />
After hosting Rodenstock’s international senior management<br />
team at ODMA, McCann says the company is in a good strong<br />
position and is currently looking to expand its presence globally,<br />
including returning to its once strong position in the New Zealand<br />
market. “The strength of the company and the strength of the<br />
brand is obviously growing globally…and certainly the feeling<br />
is that our brand is quite well-recognised in New Zealand and is<br />
viewed favourably so it would make sense to do something with<br />
that and that’s what we’re hoping to do.”<br />
McCann was in New Zealand prior to ODMA, canvassing “some<br />
key opinion leaders” about what it would take to be successful<br />
again in New Zealand. He says the company’s currently weighing<br />
up its options. “There’s nothing definite about how we do it, but<br />
we’re certainly interested. We want to make sure that the quality<br />
of the brand and the reputation of the company is maintained<br />
throughout, so it won’t be anything that will be fast but when we<br />
do it, we will do it well.” O<br />
CORNEAL LENS<br />
CORPORATION N.Z. LTD<br />
ideas into practice<br />
<strong>Sep</strong>tember <strong>2015</strong><br />
NEW ZEALAND OPTICS<br />
3